Kuchenbaecker et al.7 reported that the cumulative risk for contralateral BC is 40% for BRCA1 PV/LPV carriers and 26% for BRCA2 PV/LPV carriers, 20 years after first BC diagnosis. This evidence concerns the gene BRCA1 and breast cancer.